The Resource for your Nonhuman Primate Research

We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Recent Publications Using Our Reagents...


Activation of T cells after infusion of our Anti-CD3 [SP34R1LALA]. See Okoye's lab experimental description and results at JCI. PMID: 35316218

2022 October 21

Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses.

Lovelace, Sarah E Helmold Hait, Sabrina Yang, Eun Sung Fox, Madison L Liu, Cuiping Choe, Misook Chen, Xuejun McCarthy, Elizabeth Todd, John-Paul Woodward, Ruth A Koup, Richard A Mascola, John R Pegu, Amarendra


Anti-CD20 [2B8R1F8]-Afucosylated

2022 September 26

A novel method for in vitro culture and expansion of nonhuman primate B cells.

DeLaura, Isabel Schroder, Paul M Yoon, Janghoon Ladowski, Joseph Anwar, Imran J Ezekian, Brian Schmitz, Robin Fitch, Zachary W Kwun, Jean Knechtle, Stuart J

J Immunol Methods

Anti-CD38 [OKT10]-APC Anti-CD38 [OKT10]-PE

2022 May 16

Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy.

Varco-Merth, Benjamin D Brantley, William Marenco, Alejandra Duell, Derick D Fachko, Devin N Richardson, Brian Busman-Sahay, Kathleen Shao, Danica Flores, Walter Engelman, Kathleen Fukazawa, Yoshinori Wong, Scott W Skalsky, Rebecca L Smedley, Jeremy Axthelm, Michael K Lifson, Jeffrey D Estes, Jacob D Edlefsen, Paul T Picker, Louis J Cameron, Cheryl Ma Henrich, Timothy J Okoye, Afam A

J Clin Invest

Anti-CD3 [SP34R1LALA] Anti-CD3 [FN18]

News & Updates:

2022 Sep 08

New Anti-CD20, Anti-CD8, Anti-CD4 Antibody Reagents for Neotropical Nonhuman Primates

We now offer several new antibodies for Neotropical Nonhuman Primate species. Check them out!

2021 Feb 15

How to Cite Our Reagents Using RRIDs

We are now using Research Resource Identifiers (RRIDs) on our entire catalog to facilitate proper antibody identification. The idea behind the use of resource identifiers is simple: citation of our antibodies (using unique RRIDs) will automatically associate specific reagents with your publication.

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.